Dr. Reddy's Laboratories
has priced a public offering of 12.5 million American depositary shares at $16 each.
The offering, which is expected to close on Nov. 22, excludes the underwriter's over-allotment option.
The company previously filed a registration and preliminary supplement prospectus with the
Securities and Exchange Commission
for a proposed offering of up to 13.5 million ADS's, excluding the over-allotment.